Skip to content

Author

Mehdi Meskini Heydarlou

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Carbapenem Resistance is Associated with Biofilm formation in Clinical isolates of Klebsiella pneumoniae

Carbapenem-resistant Klebsiella pneumoniae (CRKP) and biofilm-producing nosocomial pathogenic bacteria may complicate treatment and infection control. The relationship between carbapenem resistance and biofilm formation remains poorly characterized. Susceptibility to imipenem, doripenem, ertapenem, amikacin, and levofl...

S. Jabuk, Mehdi Meskini Heydarlou, Muhammad Shawal et al. · 0 citations
Review Aug 2026

The gut microbiota-miRNA axis in multiple sclerosis: Mechanisms and therapeutic potentials.

A better understanding of the GM-miRNA axis may facilitate the development of novel biomarkers and personalized therapeutic strategies, ultimately shifting MS management from symptomatic treatment toward precision, disease-modifying interventions.

Farzaneh Rafie Sedaghat, A. Hasani, V. Poortahmasebi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.